George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Cyberduck - looks like the AZ/Oxford vaccine is standard refrigerated - stored at 2-8C - so won't have the supply chain/distribution issues Pfizers vaccine will.. The 30 million vaccines will only vaccinate 15 million people in Bangladesh (less than 10% of the population) so assume this will be targeted at the most vulnerable, health care workers (and maybe those that can pay)... They will need considerably more vaccines in the long term if they aim to undertake a proper vaccination program - so agree with you that 30 million could just be the start?
Article below may be of interest for India.
https://www.newsclick.in/Good-News-Vaccines-but-What-About-Delivery
Thanks PG.
Impressive results today with £34m profit after tax. Pure speculation but my gut feeling is the vaccine will be made available - there doesn't seem to be any point entering into the agreement if the signs weren't promising - then the lions portion of $30m added to the profit would be pretty significant and that might only be the start.
Maybe getting a bit ahead of myself :)
Hi Cyberduck - Not quite my area of expertise but it will depend how much they can piggy back the vaccine distribution onto their existing supply chain processes/procedures, already set up and in place for their current products. My best guess would be a large proportion of the $30m will be realised as profit. I'm not sure what the storage is for the AZ vaccine, but guessing it's not -80C like the Pfizer version. -80C would no doubt add to the distribution costs..
Hi Pharma G.
What are your thoughts on potential profitability with a $1 vaccine.
I read that they are receiving 30 million doses. So potential income of $30m as things stand.
Hi Pharma,
What are your thoughts regarding profit here? Of course there's no guarantee the vaccine will work but is a $1 vaccine profitable?
I read they are being provided with 30 million doses
http://m.thedailynewnation.com/news/268001/bangladesh-signs-deal-to-buy-30mn-doses-of-promising-coronavirus-vaccine
So potential added turnover of $30m as things stand.
Dhaka/ords weren't that excited by vaccine news
Perhaps sp here will drift back down to low 60p area
#waiting
Looks like it is $1 a vaccine, it was a genuine guess in my previous post..
https://www.thedailystar.net/frontpage/news/buying-3cr-vaccine-doses-govt-signs-deal-indias-sii-beximco-pharma-1990077
sure riddler was...
pumping the hell out of cns @20-25p lol
#backintheday
The price was at 86p only briefly, you'd have to have been quick to have caught it. I placed an NT trade which I don't normally "do", happy (and relieved) it was executed at 77p. Still maintain 50% of original holding. I'd consider CNS and BXP to be winners as they have provided me with decent returns so far, courtesy of the Speculator. I think Riddler was in CNS once, it was quite a few years ago now.
Well done Jolly. I'm in but clearly missed the opportune time to sell today (like I did in August!)
And yes, it's hilarious how wrong Riddler was on both BXP & CNS!
clearly spiked
but also (still) at a hefty discount to ords
I've sold down 1/2 in one pot (to 17.5k) & 1/4 in the other (down to 22.5k)
Would scale back
ceteris paribus
mid 60s
and below
The chunky rise in the share price this afternoon is clearly on the assumption that the Oxford-vaccine will get the go-ahead (licenced/approved), but we can not be sure of that just yet.
btw (yet) another extraordinarily unlucky (lol) "call" by riddler
riddler chose to mock bxp & cns @ c40p & 5.5p respectively...
you have to wonder
Jolly welcome
Thanks Jolly
p.s. or todays' DSE rise could be that Biden is good for Bangladesh imports?? - although allegedly Trump has won (or was that fake news he released?)
Hi JS -EPS/Q4 came in right on expectation though (we had the heads up of a 20% drop in Q4 with a bounce back in Q1 expected). We'll know later this month if the bounce happened ... I think the DSE rise is also based on the recent AAA rating, reassurance the divi shares are being paid out of realised profit (as I read it on the DSE news that is), and the ongoing prep for the vaccine roll out (although I've no idea how much they will get for each vaccine - could only be $1 for all I know)..
I wasn't overwhelmed by a weak 4q...
but the sp response in dhaka has been positive (up to 133/c120p)
#50%discount
it should be for both LSE (GDRs) and Dhaka ordinary shares
Impressive set of numbers. Dividend of 1.5 Tk and a 1 for 10 bonus issue of shares. Is that on the LSE as well or just Dhaka?
Nice set of results - looks like double digit growth in profits again...
We should see an RNS on Thursday morning giving us the heads up on final year results (June to June 20) + the EPS for the year, and importantly the dividend to be paid. Be interesting to see if we get 30% of profits this year.
RNS may come out later tomorrow, but more likely Thurs 7am..